634 related articles for article (PubMed ID: 2556261)
1. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
Münger K; Werness BA; Dyson N; Phelps WC; Harlow E; Howley PM
EMBO J; 1989 Dec; 8(13):4099-105. PubMed ID: 2556261
[TBL] [Abstract][Full Text] [Related]
2. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties.
Gage JR; Meyers C; Wettstein FO
J Virol; 1990 Feb; 64(2):723-30. PubMed ID: 2153238
[TBL] [Abstract][Full Text] [Related]
3. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Helt AM; Galloway DA
J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
[TBL] [Abstract][Full Text] [Related]
4. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
Dyson N; Howley PM; Münger K; Harlow E
Science; 1989 Feb; 243(4893):934-7. PubMed ID: 2537532
[TBL] [Abstract][Full Text] [Related]
5. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
6. Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor protein.
Jones RE; Heimbrook DC; Huber HE; Wegrzyn RJ; Rotberg NS; Stauffer KJ; Lumma PK; Garsky VM; Oliff A
J Biol Chem; 1992 Jan; 267(2):908-12. PubMed ID: 1309779
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
Heck DV; Yee CL; Howley PM; Münger K
Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
9. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
Barbosa MS; Edmonds C; Fisher C; Schiller JT; Lowy DR; Vousden KH
EMBO J; 1990 Jan; 9(1):153-60. PubMed ID: 2153075
[TBL] [Abstract][Full Text] [Related]
10. Point mutational inactivation of the retinoblastoma antioncogene.
Horowitz JM; Yandell DW; Park SH; Canning S; Whyte P; Buchkovich K; Harlow E; Weinberg RA; Dryja TP
Science; 1989 Feb; 243(4893):937-40. PubMed ID: 2521957
[TBL] [Abstract][Full Text] [Related]
11. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
Zhang B; Chen W; Roman A
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
Helt AM; Funk JO; Galloway DA
J Virol; 2002 Oct; 76(20):10559-68. PubMed ID: 12239337
[TBL] [Abstract][Full Text] [Related]
13. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein.
Jones RE; Wegrzyn RJ; Patrick DR; Balishin NL; Vuocolo GA; Riemen MW; Defeo-Jones D; Garsky VM; Heimbrook DC; Oliff A
J Biol Chem; 1990 Aug; 265(22):12782-5. PubMed ID: 2198278
[TBL] [Abstract][Full Text] [Related]
14. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
15. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
Scheffner M; Münger K; Huibregtse JM; Howley PM
EMBO J; 1992 Jul; 11(7):2425-31. PubMed ID: 1321031
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of human papillomavirus type 16 E7 by complementation with adenovirus E1A mutants.
Davies RC; Vousden KH
J Gen Virol; 1992 Aug; 73 ( Pt 8)():2135-9. PubMed ID: 1322963
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
